Reverted stellate cells and uses thereof

The present invention relates to a composition for treating fibrosis comprising EGF and/or FGF2, and optionally at least one dietary fatty acid. The present invention also relates to a process for reverting activated stellate cells, preferably hepatic stellate cells, and to reverted stellate cells obtained by such process. The present invention also relates to in vitro methods for determining the pro- or anti-fibrotic activity of an agent.

Octrooi-publicatienummer: WO2017005886

Jaar aanvraag: 2016

Jaar toekenning: 2018

Gevalideerd voor IOF-sleutel: Ja

Toegewezen aan: Universitaire Associatie Brussel